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Background
The cross-sectional nature of our previous study by late
gadolinium enhancement (LGE) cardiovascular magnetic
resonance (CMR) in systemic right ventricle (RV) patients
limited our ability to make conclusions about the prog-
nostic predictive value of LGE in this population. There-
fore, we performed this larger prospective study to
determine whether fibrosis detected by LGE CMR would
predict adverse outcomes in patients treated for transpo-
sition of the great arteries by atrial redirection surgery
with RV in the systemic position and at risk of arrhyth-
mia, premature RV failure, and sudden death.
Methods
Fifty-five patients (aged 27±7 years) underwent LGE
CMR and were followed for a mean of 6.5±3.2 years in
a single-centre study. The pre-specified composite clini-
cal endpoint consisted of new-onset sustained atrial/ven-
tricular tachyarrhythmia or decompensated heart failure
admission/transplantation/death.
Results
RV LGE was present in 31 (56%) patients. In 8 out of 9
(89%) patients with more than one event, atrial tachyar-
rhythmia, itself a known risk factor for mortality,
occurred first. Univariate predictors of the composite
endpoint (n=22 patients; 19 atrial/2 ventricular tachyar-
rhythmia, 1 death) included RV LGE presence and
extent, RV volumes/mass/ejection fraction, right atrial
area, peak VO2 and age at repair. In bivariate analysis,
RV LGE presence was independently associated with the
composite endpoint, and remained significant (hazard
ratio (HR) 4.95[95% confidence interval (CI) 1.60-15.28],
p=0.005) when compared with the second independent
predictor, percent predicted peak VO2 (HR 0.80[95% CI
0.68-0.95],p=0.009 per 5%). When fibrosis status was
added to peak VO2%, risk prediction for cardiac events
was further refined.
There was clear agreement between location and
extent of RV LGE at in vivo CMR and histologically
documented focal RV fibrosis in an explanted heart
from one of the study patients. Lastly, RV LGE appeared
progressively extended in another patient from our
cohort restudied for clinical indication.
Conclusions
LGE in the systemic RV was commonly found in our
cohort of adult patients late after atrial redirection sur-
gery for transposition of the great arteries and is a strong
and independent predictor of adverse clinical outcome.
RV LGE should therefore be incorporated in risk stratifi-
cation for adverse cardiac outcomes in these patients.
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